Breast Cancer Quad, IHC

Breast Cancer Quad Marker Panel, IHC

Test Overview

The Breast Cancer Quad Marker Panel by Immunohistochemistry (IHC) is an advanced diagnostic test used to evaluate four important biomarkers in breast cancer tissue. This panel helps oncologists classify the cancer type, assess prognosis, and guide targeted treatment decisions.

Markers Included

• Estrogen Receptor (ER)
• Progesterone Receptor (PR)
• HER2/neu
• Ki-67 Proliferation Index

Why This Test is Important

• Supports accurate breast cancer classification
• Helps determine hormone responsiveness
• Assists in selecting targeted therapies
• Evaluates tumor aggressiveness and growth rate
• Aids in personalized treatment planning

Sample Required

• Formalin Fixed Paraffin Embedded (FFPE) Tissue Block / Slides

Method

• Immunohistochemistry (IHC)

Recommended For

• Newly diagnosed breast cancer patients
• Treatment planning and prognosis evaluation
• Monitoring biomarker status in tumor tissue

Reporting Time

• As per laboratory protocol

#BreastCancer #IHC #CancerDiagnostics #HER2 #ERPR #Ki67 #OncologyTesting #Pathology #BiocareLaboratories #Dermafact #gynofact